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ABSTRACT
Antimonials remain the first line drug against the
protozoan parasite Leishmania but their efficacy
is threatened by resistance. We carried out a
RNA expression profiling analysis comparing an
antimony-sensitive and -resistant (Sb2000.1) strain
of Leishmania infantum using whole-genome
70-mer oligonucleotide microarrays. Several genes
were differentially expressed between the two
strains, several of which were found to be physically
linked in the genome. MRPA, an ATP-binding cas-
sette (ABC) gene known to be involved in antimony
resistance, was overexpressed in the antimony-
resistant mutant along with three other tandemly
linked genes on chromosome 23. This four gene
locus was flanked by 1.4kb repeated sequences
from which an extrachromosomal circular amplicon
was generated in the resistant cells. Interestingly,
gene expression modulation of entire chromo-
somes occurred in the antimony-resistant mutant.
Southern blots analyses and comparative genomic
hybridizations revealed that this was either due to
the presence of supernumerary chromosomes or to
the loss of one chromosome. Leishmania parasites
with haploid chromosomes were viable. Changes in
copy number for some of these chromosomes were
confirmed in another antimony-resistant strain.
Selection of a partial revertant line correlated
antimomy resistance levels and the copy number
of aneuploid chromosomes, suggesting a putative
link between aneuploidy and drug resistance in
Leishmania.
INTRODUCTION
The protozoan parasite Leishmania is the etiological agent
of a group of diseases termed leishmaniasis. Human leish-
maniasis has a prevalence of 12 million cases, an estimated
population of 350 million at risk and an incidence of
2 million new cases annually (1). No eﬀective vaccine is
yet available against this parasite and its control relies
primarily on chemotherapy. Pentavalent antimony con-
taining compounds such as sodium stibogluconate
(Pentostam) and N-methylglucamine (Glucantime)
remain the mainstay against all forms of Leishmania infec-
tions (1), but their eﬃcacy is threatened by antimony-resis-
tant parasites now described on a frequent basis in several
endemic regions (2–4). Other drugs include pentamidine
and amphotericin B but severe side eﬀects and high cost
have limited their widespread use. The aminoglycoside
paromomycin is now more frequently used (1,5,6) and
the ﬁrst oral drug miltefosine shows promising eﬃcacy
despite evidence suggesting that resistance could develop
rapidly (7). Since there are few new drugs in the pipeline
(5,8–11) and resistance to ﬁrst-line drug(s) has a signiﬁcant
therapeutic impact on this important parasitic disease, a
better understanding of the molecular and biochemical
mechanisms leading to resistance is warranted.
The mechanisms involved in antimony resistance in
Leishmania are partly understood, at least in in vitro
selected antimony-resistant strains. These are mainly asso-
ciated with a reduced activation or an altered transport of
the drug. Pentavalent antimony (SbV) is believed to be
a prodrug that requires biological reduction to its
trivalent form (SbIII) in either the host macrophages
and/or the parasites to acquire antileishmanial activity
[reviewed in (5,8)] and a decreased SbV reduction rate
has been reported in sodium stibogluconate-resistant
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been shown to be mediated by aquaglyceroporins and
downregulation of aquaglyceroporin 1 (AQP1) was asso-
ciated with an increased SbIII resistance (13,14).
Furthermore, an increased level of trypanothione (TSH),
the main cellular thiol in Leishmania (15), has been
observed in mutants selected for antimony resistance
(16–21) and could help to restore thiol redox potential
which is perturbed following antimony accumulation
(22,23). Increased levels of TSH also allow for the forma-
tion of thiol adducts of antimony that are either detoxiﬁed
by their transport inside an intracellular organelle by the
ATP-binding cassette (ABC) transporter MRPA or
extruded from the parasite by an unidentiﬁed plasma
membrane eﬄux system. The increased expression of
MRPA is often due to the ampliﬁcation of its gene in
antimony-resistant strains (16,24,25). Other genes and
proteins including a heat-shock protein 70 (26), a heat-
shock protein 83 (27), a protein of the leucine-rich repeats
(LRRs) superfamily (28), an ampliﬁed DNA from ﬁeld
isolates (29), a tryparedoxin peroxidase (30) and a very
large polypeptide (31) were also associated with an
increased tolerance toward antimony in some parasites.
Several, but not all, of the antimony resistance mechan-
isms identiﬁed while studying in vitro selected mutants
were also found in resistant ﬁeld isolates (2,22,32–36).
Resistance to antimonials seems to implicate several
mutational events co-existing within the same cell (8).
Accordingly, the simultaneous analysis of the whole
genome could provide useful information about the com-
plex events leading to resistance to this class of drugs.
Small targeted DNA microarrays have already shown
their usefulness in studying drug resistance mechanisms
in Leishmania (17,37,38). In order to study gene expres-
sion modulation associated with antimony resistance on a
full-genomic scale, we have carried out a RNA expression
proﬁling experiment comparing an antimony-sensitive
(WT) and an antimony-resistant (Sb2000.1) strain
of Leishmania infantum using recently generated whole-
genome 70-mer oligonucleotide microarrays for
Leishmania (39,40). These experiments pinpointed speciﬁc
mechanisms and novel changes in ploidy (supernumerary
chromosomes and monosomy) that were correlated to
resistance.
MATERIALS AND METHODS
Celllines
Leishmania infantum promastigotes were grown at 258C
in SDM-79 medium supplemented with 10% heat-
inactivated fetal bovine serum and 10 mg/ml hemin. The
L. infantum wild-type (WT) strain (MHOM/MA/67/
ITMAP-263), the L. infantum Sb2000.1 mutant (37) and
the L. infantum Sb4000.4 mutant (38) selected for SbIII
resistance have been described previously. The L. infantum
Sb400.2 and Sb1000.3 mutants were selected from a
cloned parental population using a stepwise selection
until they were resistant to 400 and 1000 mM SbIII, respec-
tively. The L. infantum Sb2000.1 mutant was grown in
the absence of SbIII for 30 passages in order to obtain
a (partial) revertant line. Leishmania promastigotes were
transfected by electroporation as reported previously (41).
Growth curves were obtained by measuring absorbance at
600nm of a 200-ml culture aliquot at 72h using an auto-
mated microplate reader.
DNA manipulations
Total DNA was isolated using DNAzol reagent
(Invitrogen) as recommended by the manufacturer. For
quantitative Southern blots, the genomic DNA was
digested with BamHI and EcoRV and migrated overnight
at 30V in 0.7% agarose gels. Southern blots, hybridi-
zations and washes were performed following standard
protocols (42) and all probes were obtained by PCR.
Densitometric analyses of Southern blots were performed
using ImageQuant 5.2 (Molecular Dynamics). The
pSPaNEOa-MRPA construct has been described pre-
viously (43). The LinJ32_V3.2190 inactivation cassette
was generated using the folowing PCR primers: primer
1, 50-GCTCTAGAAGCTCCTGCGGTTTGCCTAC and
primer 2, 50-CCGTTATTGTGCCGACTGCCGGATCC
GGGTGCGGAGTATGAAGGATG to amplify a
region of 600-bp upstream of the gene and primer 3,
50-GGCAGTCGGCACAATAACGG; and primer 4,
50-CCCAAGCTTGGGTGTCACGCAGCTCCTTG in
order to amplify a DNA fragment of 600-bp downstream
of the gene. The upstream and downstream fragments
were fused by PCR using primers 1 and 4 and the resulting
DNA fragment was cloned in the pGEM-T-easy vector
leading to the pGEM-UP/DOWN-32 vector. The XbaI,
BamHI and HindIII restriction sites are underlined in the
primers. An a-NEO-a cassette was isolated from the
vector pSP72 a-NEO-a by digestion with BamHI and
cloned in a unique BamHI restriction site located between
the upstream and downstream fragments in pGEM-UP/
DOWN-32 leading to the pGEM-KO32NEO plasmid.
The LinJ32_V3.2190 inactivation cassette was isolated
from pGEM-KO32NEO by an XbaI-HindIII digest and
transfected in L. infantum WT, Sb2000.1 and Sb2000.1rev
as previously described. The integration of the inactiva-
tion cassette at the LinJ32_V3.2190 locus was conﬁrmed
by PCR using the primers 50- CAATACGCACGATGCA
CAGG and 50-ACAACGTCGAGCACAGCTGC, and by
Southern blots. Genomic DNA labeling was performed as
previously described (40).
Microarray design
The recent completion of the genome sequencing of
L. major (44) and L. infantum (45) has allowed the gener-
ation of multispecies high-density oligonucleotide micro-
arrays as previously described (39,40).
RNA isolation and labeling
Total RNA was isolated from 10
8 Leishmania cells during
the mid-log phase of growth using the RNeasy Plus Mini
Kit (Qiagen) as described by the manufacturer. The RNAs
were treated with RNase-free DNAse I Turbo (Ambion)
to avoid any genomic contamination. The quality and
quantity of RNA were assessed using RNA 6000 Nano
Assay chips on a Bioanalyzer 2100 (Agilent technologies).
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three clear ribosomal peaks (18S, 24Sa and 24Sb) and the
absence of RNA degradation. Ten micrograms of RNA
were converted to aminoallyl-dUTP incorporated cDNA
using random hexamers (Roche) and the SuperScript III
Rnase H-Reverse Transcriptase (Invitrogen). Aminoallyl-
dUTP incorporated cDNAs were thereafter coupled to
Alexa Fluor 555 or Alexa Fluor 647 following manufac-
turer recommendations. Fluorescent cDNAs were puriﬁed
with MinElute Spin Column (Qiagen) and quantiﬁed
spectrophotometrically.
Microarrays hybridization
Pre-hybridization and hybridization were performed
as previously described (39,40). Hybridizations were per-
formed in ﬁve replicates using ﬁve independent RNA
extractions and dye swapping.
Microarray data acquisition and analysis
Detection of the Alexa Fluor 555 and Alexa Fluor 647
signals was performed on a G2565CA DNA microarray
scanner (Agilent technologies) at a 5-mm resolution. The
signal intensity data were extracted from the primary
scanned images using the GenePix Pro 6.0 software
(Axon Technologies). Raw data were imported and nor-
malization and statistical analyses were performed in R
2.2.1 using the LIMMA (Linear Models for Microarray
Data) 2.7.3 package (46–48) as previously described (40).
Multiple testing corrections were done using the false dis-
covery rate method with a threshold P-value of 0.05. Only
genes statistically signiﬁcant with an absolute log2-trans-
formed expression ratio greater than 0.58 were considered
as diﬀerentially expressed. GeneSpring GX 3.1 was used
for the generation of the chromosome map of expression
ratios. The entire dataset was deposited to GEO under the
reference number series GSE9949.
Real-time RT-PCR
Three independent RNA preparations were used for
each real-time PCR experiment. First-strand cDNA was
synthetized from 10mg of RNA using random hexamers
(Roche) and the SuperScript III RNase H-Reverse
Transcriptase (Invitrogen) according to the manufacturer
recommendations. Equal amounts of cDNA were run in
triplicate and ampliﬁed in 15ml reactions containing 7.5 ml
of 2X Universal PCR Master Mix (Applied Biosystems),
10 nM Z-tailed forward primer, 100 nM reverse primer,
250 nM Ampliﬂuor Uniprimer probe (Chemicon) and 1ml
cDNA target. Mixtures were incubated at 508C for 2min,
at 958C for 4min and then cycled 55 times at 958C for 15s
and at 558C for 30s using an Applied Biosystems Prism
7900 Sequence Detector at the Gene Quantiﬁcation Core
Laboratory of the Centre de Ge ´ nomique de Que ´ bec
(https://genome.ulaval.ca/qrtpcr). No-template controls
were used as recommended. Ampliﬁcation was normalized
to the LinJ18_V3.0630 and LinJ36_V3.0850 genes, for
which a highly stable expression was noted in several
conditions by diﬀerent microarrays experiments, before
quantities of target genes were calculated according
to standard curves using the REST 2005 software
(Corbett Life Science). Primers were designed using
Primer Express 2.0 (Applied Biosystems).
RESULTS
Gene expression profiling inL. infantum antimony-
resistantmutants
The completion of the L. major (44) and L. infantum (45)
genome sequences allowed the generation of full genome
70-mer oligonucleotides DNA microarrays suitable for
genome-wide expression proﬁling analyses in L. major
and L. infantum (39,40). The arrays were used to study
gene expression modulation associated with antimony
resistance in the L. infantum Sb2000.1 mutant. This
mutant is highly resistant to SbIII compared to its paren-
tal sensitive WT strain (Figure 1). The Sb2000.1 mutant
has already been studied with small targeted arrays of 50
genes (37,38) but not at the whole genome level. The log2-
transformed gene expression ratios of Sb2000.1 compared
to its parental strain are shown in Figure 2. The majority
of the spots aligned along the line of best ﬁt, suggesting
that genes represented by these spots were equally
expressed in both samples. Nonetheless, when applying a
cutoﬀ of at least 2-fold diﬀerential expression (P < 0.05),
24 genes were signiﬁcantly modulated at the RNA level in
the Sb2000.1 mutant (Table 1). These included the gene
coding for the ABC transporter MRPA whose ampliﬁca-
tion in Sb2000.1 has previously been reported (37,38).
When the cutoﬀ was adjusted from a 2-fold to a 1.5-fold
diﬀerence in mRNA abundance (P < 0.05), a total of 84
genes were found to be signiﬁcantly modulated in the
Sb2000.1 mutant (Table 1).
DNA microarrays data were conﬁrmed by real-time
quantitative RT-PCR (qRT-PCR) experiments performed
on a set of 21 selected genes (19 test genes and 2 control
genes) and the two techniques correlated, with only few
discrepant results (Figure 3A). Indeed, whereas
LinJ26_V3.0120 was found downregulated using DNA
microarrays ( 1.6-fold), it was found overexpressed in
the qRT-PCR experiments (+1.7-fold), although not at a
signiﬁcant level. Furthermore, whereas LinJ14_V3.1450
and LinJ20_V3.1740 were signiﬁcantly upregulated using
DNA microarrays, their overexpression was determined as
not signiﬁcant in the qRT-PCR experiments. The remain-
ing genes showed similar signiﬁcant diﬀerences in mRNA
abundance whether they were analyzed by qRT-PCR or
DNA microarrays. Genes whose expressions are modu-
lated in several independent resistant mutants would
make good candidate drug resistance genes. Therefore, in
order to link speciﬁc gene expression modulation with anti-
mony resistance, the expression of the same set of selected
genes was assayed by qRT-PCR in another independently
selected antimony-resistant line, the L. infantum Sb4000.4
mutant. Out of the 16 genes signiﬁcantly modulated in
Sb2000.1 by qRT-PCR, 7 were also diﬀerentially expressed
in Sb4000.4 (Figure 3B). The other nine genes were either
not modulated at a signiﬁcant level or were inversely regu-
lated in Sb4000.4. With its 4-fold decreased expression,
LinJ05_V3.0830 was the gene that showed the highest
fold diﬀerence in both mutants, apart from
Nucleic Acids Research,2009, Vol.37, No. 5 1389LinJ23_V3.0290 (MRPA) (Figure 3A and B). This is the
ﬁrst report of LinJ05_V3.0830 being downregulated in
antimony-resistant mutants of Leishmania and interest-
ingly this gene was also shown to be highly downregulated
in two other independently selected SbIII-resistant
L. infantum strains, the Sb400.2 and Sb1000.3 mutants
(Figure 3C). Since the expression of seven genes was sim-
ilarly modulated in two independent mutants, we per-
formed transfection experiments to test whether any of
these genes could be involved in antimomy resistance.
The upregulated and downregulated genes were trans-
fected in L. infantum WT and Sb2000.1, respectively.
However, under our experimental conditions, we did not
observe a change in susceptibility to SbIII except for cells
transfected with LinJ23_V3.0290 (MRPA) (data not
shown and Figure 1), suggesting that if the genes tested
are involved in resistance it is through indirect means.
Extrachromosomal circular amplification ofa genelocus
onchromosome 23
The data generated from the microarray hybridizations
can be illustrated by a chromosome map representing
Table 1. Genes signiﬁcantly modulated in L. infantum Sb2000.1 as
determined by microarrays
 
GeneDB V3.0
systematic ID
Gene description Fold
diﬀerence
Downregulated in L. infantum Sb2000.1
LinJ02_V3.0520 Hypothetical protein, unknown function  1.72
LinJ03_V3.0360 Hypothetical protein, conserved  2.08
LinJ05_V3.0280 Protein tyrosine phosphatase, putative  1.73
LinJ05_V3.0830 Methylthioadenosine phosphorylase,
putative
 3.01
LinJ06_V3.1280 Hypothetical protein, conserved  2.60
LinJ06_V3.1340 Protoporphyrinogen oxidase-like protein  1.74
LinJ06_V3.1350 Hypothetical protein, unknown function  2.00
LinJ09_V3.0100 RNA-binding protein 5-like protein  1.70
LinJ09_V3.0580 LRR protein, putative  1.70
LinJ09_V3.0650 Cyclin 1, putative  1.78
LinJ09_V3.0690 Hypothetical protein, conserved  2.00
LinJ09_V3.0970 Calmodulin, putative  1.89
LinJ09_V3.0980 Calmodulin, putative  1.89
LinJ09_V3.1050 Hypothetical protein, conserved  1.69
LinJ12_V3.0010 Surface antigen protein 2, putative  1.88
LinJ12_V3.0020 Surface antigen protein 2, putative  1.75
LinJ12_V3.0040 Surface antigen protein 2, putative  1.88
LinJ12_V3.0080 No description  1.88
LinJ12_V3.0110 Surface antigen protein, putative  1.99
LinJ12_V3.0120 HGPRT,hypoxanthine-guanine
phosphoribosyltransferase
 1.77
LinJ12_V3.0130 XRPT, xanthine
phosphoribosyltransferase
 1.87
LinJ12_V3.0290 Hypothetical protein, unknown function  1.72
LinJ12_V3.0350 30-nucleotidase/nuclease, putative  1.68
LinJ12_V3.0680 Surface antigen protein 2, putative  1.75
LinJ12_V3.0690 Surface antigen protein 2 precursor  1.88
LinJ17_V3.0120 Receptor-type adenylate cyclase a  1.80
LinJ18_V3.1640 Hypothetical protein, conserved  1.76
LinJ23_V3.1830 Hypothetical protein, unknown function  1.79
LinJ23_V3.1930 Hypothetical protein, conserved  1.98
LinJ26_V3.0120 Adenine phosphoribosyltransferase  1.85
LinJ29_V3.0260 Oxidase-like protein  2.81
LinJ30_V3.2870 Hypothetical protein, conserved  1.73
LinJ31_V3.0610 Amino acid transporter aATP11,
putative
 1.72
LinJ31_V3.0430 Calpain-like cysteine peptidase, putative  1.87
LinJ31_V3.1240 Vacuolar-type proton translocating
pyrophosphatase 1
 1.94
LinJ31_V3.2380 30-nucleotidase/nuclease precursor,
putative
 2.59
LinJ32_V3.0240 Dynein light chain, ﬂagellar outer arm,
putative
 1.79
LinJ32_V3.0360 Hypothetical protein, conserved  1.70
LinJ32_V3.0690 Centrin, putative  1.79
LinJ32_V3.1760 Hypothetical protein, conserved  2.57
LinJ32_V3.2020 Hypothetical protein, conserved  1.96
LinJ32_V3.2030 Hypothetical protein, conserved  1.72
LinJ32_V3.2150 COP-coated vesicle membrane protein
p24 precursor
 1.84
LinJ32_V3.2400 Hypothetical protein, unknown function  2.33
LinJ32_V3.3100 Nucleoside diphosphate kinase b  1.69
LinJ32_V3.3110 Nucleoside diphosphate kinase b  1.69
LinJ32_V3.3350 Hypothetical protein, conserved  1.79
LinJ32_V3.4080 Hypothetical protein, conserved  1.71
LinJ34_V3.2150 Hypothetical protein, unknown function  1.87
LinJ35_V3.1050 Hypothetical protein, unknown function  2.06
LinJ36_V3.0430 Hypothetical protein, conserved  1.71
Upregulated in L. infantum Sb2000.1
LinJ01_V3.0470 a/b-hydrolase-like protein 2.24
LinJ01_V3.0540 Long chain fatty acid CoA ligase,
putative
1.77
LinJ11_V3.0020 Hypothetical protein, conserved 1.89
(continued)
Figure 1. Antimony susceptibilities in L. infantum. Growth of
L. infantum promastigote cells in the presence of increasing concentra-
tions of SbIII was monitored at 72h by OD mesurements at 600nm.
The average of three experiments is shown. Leishmania infantum WT
(open circles); L. infantum Sb2000.1 (ﬁlled circles); L. infantum
Sb2000.1rev P30 (open squares); L. infantum Sb2000.1rev P30 trans-
fected with pSPaNEOa-MRPA (ﬁlled squares).
Figure 2. Gene expression proﬁling of antimony-resistant L. infantum
promastigotes. Plot of log2-transformed Sb2000.1/WT expression ratios
as a function of hybridization intensities. An average of ﬁve indepen-
dent experiments is presented. External lines and dashed lines indicate
2- and 1.5-fold diﬀerences, respectively.
1390 Nucleic Acids Research, 2009, Vol. 37,No. 5gene expression levels on a genomic scale (Figure 4). The
expression ratios of every gene on a particular chromo-
some is represented by a color code with overexpressed
genes shown as orange to red features, downregulated
genes shown as pale to bright green features and unmo-
dulated genes shown as yellow features. This representa-
tion enabled the identiﬁcation of a locus on chromosome
23 that was clearly overexpressed in Sb2000.1 (Figure 4,
red locus on chromosome 23). A close examination of the
expression data derived from the microarrays allowed to
precisely deﬁne the genes located on this overexpressed
locus. Indeed, the overexpressed genomic region com-
prises the genes LinJ23_V3.0270, LinJ23_V3.0280,
LinJ23_V3.0290 (MRPA) and LinJ23_V3.0300
(Figure 5A), which were all substantially upregulated in
Table 1. Continued
GeneDB V3.0
systematic ID
Gene description Fold
diﬀerence
LinJ11_V3.0030 Hypothetical protein, conserved 1.69
LinJ11_V3.0040 ABC transporter, putative 1.75
LinJ11_V3.0080 Hypothetical protein, conserved 1.68
LinJ11_V3.0130 NGG1 interacting factor 3-like protein 1.72
LinJ11_V3.0170 Hypothetical protein, conserved 1.71
LinJ11_V3.0180 Hypothetical protein, conserved 2.13
LinJ11_V3.0210 Acidocalcisomal pyrophosphatase 1.99
LinJ11_V3.0240 Proteasome alpha 7 subunit, putative 2.08
LinJ11_V3.0520 Nucleoside transporter-like protein 2.49
LinJ11_V3.0550 Amino acid permease/transporter,
putative
1.78
LinJ11_V3.0560 Protein kinase, putative 1.71
LinJ11_V3.0570 Hypothetical protein, conserved 2.09
LinJ11_V3.0580 Tetratricopeptide repeat (TPR) protein 1.86
LinJ11_V3.0590 Hypothetical protein, conserved 1.83
LinJ11_V3.0680 Hypothetical protein, conserved in
leishmania
1.88
LinJ11_V3.0690 Hypothetical protein, conserved in
leishmania
1.88
LinJ11_V3.0730 Hypothetical protein, conserved 1.95
LinJ14_V3.1420 d-6 fatty acid desaturase, putative 1.69
LinJ14_V3.1450 Myo-inositol-1-phosphate synthase 2.27
LinJ17_V3.0390 Hypothetical protein, conserved 1.76
LinJ19_V3.0870 Pteridine transporter, putative 1.70
LinJ20_V3.1740 Aminoacylase, putative 2.35
LinJ23_V3.0270 Hypothetical protein, conserved 4.30
LinJ23_V3.0280 Terbinaﬁne resistance locus protein
(yip1)
8.50
LinJ23_V3.0290 Multidrug resistance protein, putative 5.39
LinJ23_V3.0300 Argininosuccinate synthase, putative 5.59
LinJ23_V3.0700 Hypothetical protein 1.92
LinJ25_V3.0740 Eukaryotic initiation factor 5a, putative 1.91
LinJ25_V3.0750 Eukaryotic initiation factor 5a, putative 1.91
LinJ25_V3.0760 Eukaryotic initiation factor 5a, putative 1.91
LinJ25_V3.1040 Hypothetical protein, conserved 2.02
LinJ25_V3.1210 ATPase b subunit, putative 1.80
LinJ25_V3.1680 Hypothetical protein, conserved 1.69
LinJ25_V3.1700 Hypothetical protein, conserved 1.71
LinJ25_V3.2260 Hypothetical protein, conserved 1.68
LinJ25_V3.2360 Hypothetical protein, conserved 1.69
LinJ25_V3.2580 ATPase b subunit, putative 1.96
LinJ29_V3.1320 Hypothetical protein, conserved 1.73
LinJ29_V3.2940 Hypothetical protein, conserved 1.88
LinJ31_V3.0750 Hypothetical protein, conserved 2.16
LinJ33_V3.3260 Hypothetical protein, conserved 1.77
LinJ33_V3.3390 h1 histone-like protein 2.15
 P<0.05.
Figure 3. Validation of DNA microarrays expression data by quanti-
tative real-time RT-PCR (qRT-PCR). (A) The mean log2-transformed
Sb2000.1/WT ratios of selected genes from microarrays expression data
(black bars) are compared to qRT-PCR data (grey bars). (B) The
mean log2-transformed Sb2000.1/WT (black bars) and Sb4000.4/WT
(grey bars) qRT-PCR expression ratios of a group of selected genes.
(C) The mean log2-transformed qRT-PCR expression ratios
of LinJ05_V3.0830 and LinJ23_V3.0290 in diﬀerent L. infantum
antimony-resistant mutants compared to the parental WT strain. The
qRT-PCR data were normalized with the LinJ18_V3.0630 and
LinJ36_V3.0850 genes, for which a highly stable expression was
noted in several conditions by diﬀerent microarrays experiments. An
asterix beside the bars indicates a signiﬁcant fold diﬀerence (P<0.05).
Nucleic Acids Research,2009, Vol.37, No. 5 1391Sb2000.1, while the genes located on each side of this four
genes locus (LinJ23_V3.0260 and LinJ23_V3.0310) were
not diﬀerentially expressed. Alkaline lysis allowed the
recovery of a circular amplicon from Sb2000.1
(Figure 5C) that hybridized with a MRPA probe (data
not shown) indicating that the increased gene expression
observed by DNA microarrays at the MRPA locus
resulted from the circular ampliﬁcation of the small over-
expressed genomic region. Generation of circular ampli-
cons in Leishmania is often due to homologous
recombination between direct repeats (24,25,49,50) and a
close examination of the sequences bordering the ampli-
ﬁed locus indeed revealed the presence of a 1389-bp
repeated sequence of 100% nucleotide identity on each
side of the locus ampliﬁed (Figure 5A). These direct
repeats were also found on chromosome 23 of L. major
and L. braziliensis (data not shown). To ascertain that
the extrachromosomal circular amplicon was generated
from homologous recombination between these direct
repeats, a pair of PCR primers was designed to amplify
a DNA fragment of 1.8kb only from an extrachromoso-
mal circular DNA template created by the recombination
of the repeats and not from the chromosomal locus
(Figure 5A). As expected, ampliﬁcation of the 1.8-kb
DNA fragment was observed from total DNA of
L. infantum Sb2000.1 while no ampliﬁcation was observed
from total DNA of L. infantum WT (Figure 5D).
Sequencing of the PCR fragment conﬁrmed that the
circle was formed by homologous recombination between
the repeated sequences (data not shown).
Figure 4. Chromosome map of L. infantum Sb2000.1/WT gene expression modulation. DNA microarrays data were analyzed with the GeneSpring
GX3.1 software to illustrate the Sb2000.1/WT expression ratios on a chromosome map of L. infantum. Orange to red features indicate genes
overexpressed in Sb2000.1, whereas pale to bright green features indicate genes downregulated in Sb2000.1. Yellow features indicate genes equally
expressed in both samples. (Insert) Log2-transformed Sb2000.1/WT expression ratios plotted as a function of the chromosomal location of every
probes represented on the full-genome microarrays from chromosome 1 (left end) to chromosome 36 (right end). Probes are plotted by coordinates
along each chromosome. Vertical bars represent the log2-transformed expression ratio of individual genes. Whereas most of the genes represented by
the microarrays do not show a modulated expression, some chromosomes are entirely overexpressed or downregulated at the RNA level. (A)
chromosome 1; (B) chromosome 11; (C) overexpressed locus on chromosome 23; (D) chromosome 25; (E) chromosome 9; (F) chromosome 12;
(G) chromosome 32. The plot represents the average values of ﬁve independent hybridizations.
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The expression of whole chromosomes seemed to be
modulated in L. infantum Sb2000.1, as suggested by the
chromosome map of gene expression ratios (Figure 4).
Indeed, whereas genes from chromosomes 1, 11 and 25
were mostly overexpressed (predominantly colored in
red), those of chromosomes 9, 12 and 32 were mostly
downregulated (predominantly colored in green). A close
analysis of the normalized expression data generated by
the microarray experiments conﬁrmed that most genes
located on these chromosomes were modulated by a
factor ranging from 1.5 to 2 in mRNA abundance (data
not shown). Plotting the gene expression data as a func-
tion of microarray probes ordered by chromosomal loca-
tion for the entire genome (insert in Figure 4) or for
selected chromosomes (Figure 6) conﬁrmed the uniform
gene expression modulation of these chromosomes.
Although a number of hypotheses could explain this
phenomenon, one favored explanation for the modula-
ted expression of entire chromosomes would be a
concomitant-speciﬁc change in the number of allele for
these chromosomes. This contention received support
from quantitative Southern blot hybridizations since the
DNA contents of chromosomes 1, 11 and 25 were, respec-
tively, increased by 1.6-, 2- and 1.6-fold in Sb2000.1
(Figure 6A, B and C, lanes 1 and 2), while those of chro-
mosomes 12 and 32 (Figure 6E and F, lanes 1 and 2) were
decreased by 2-fold in this mutant. Conversely, whereas
the microarray data indicated that the gene expression of
the entire chromosome 9 was decreased in L. infantum
Sb2000.1, its DNA content was unchanged compared to
L. infantum WT (Figure 6D, lane 1 and 2). Interestingly,
the DNA content of chromosome 11 was also increased in
the Sb4000.4 antimony-resistant mutant (Figure 6B, lane
3) and the DNA content of the entire chromosome 12 was
also decreased in this independently selected strain
(Figure 6E, lane 3). As a control, chromosome 30,
whose gene expression was unchanged in the microarray
data, showed equal DNA contents in L. infantum
WT, Sb2000.1 and Sb4000.4 (Figure 6A–F). The 2–4
chromosome-speciﬁc probes used for DNA hybridizations
were physically located far apart from each other and the
data supported a change in ploidy for the entire chromo-
somes. This was further conﬁrmed by comparative geno-
mic hybridization experiments (CGH) that revealed a
change in ploidy for several chromosomes in L. infantum
Sb2000.1. Indeed, the DNA copy number correlated well
with the mRNA proﬁle and changes were constant along
the whole chromosome length (Figure 7). Statistical ana-
lysis of the median signal diﬀerence for each chromosome
also conﬁrmed whole chromosome copy number changes
whether the microarrays were hybridized to cDNA or
genomic DNA (data not shown).
A correlation between aneuploidy and drug resistance
has already been described in yeast (51). In order to verify
if the aneuploidy observed in Sb2000.1 and Sb4000.4
could be associated with antimony resistance, a partial
revertant line of Sb2000.1 (Sb2000.1rev) was generated
by successive passages in the absence of antimony.
The SbIII resistance level of the revertant line decreased
in cells that have grown for passages in the absence of
drug but never completely reverted to the parental wild-
type level (Figure 1). The decreased resistance after 30
passages in the absence of SbIII was correlated with the
concomitant loss of the extrachromosomal amplicon car-
rying MRPA (Figures 1 and 8A) and with the regression
of the aneuploidy of chromosomes 1, 11 and 25 to wild-
type ploidy (Figures 1 and 8B). Interestingly, resistance in
cells grown for 10 passages without drug were not less
resistant than the parent mutant (data not shown) but
also their polyploidy was not changed (Figure 8).
Furthermore, the transfection of MRPA into the revertant
line at passage 30 only partially restored the resistance to
antimony observed in the parental mutant (Figure 1), an
observation that further circumstantially links the anti-
mony resistance levels and the supernumerary chromo-
somes. Finally, the L. infantum Sb2000.1 mutant and its
revertant strain appeared haploid for chromosomes 12
and 32, a genotype that remained stable for 30 passages
without antimony (Figure 8C) and that correlated with the
remaining SbIII resistance levels observed in L. infantum
Sb2000.1revP30 (Figure 1). Despite their partial haploid
genome, the Sb2000.1 mutant and its revertant line
divided at the same rate as wild-type cells (data not
shown). To further conﬁrm the monosomy of chromo-
some 32, we tested whether a single round of allelic inac-
tivation would lead to a null mutant in Sb2000.1 and
Sb2000.1rev. We chose LinJ32_V3.2190, a gene coding
for an unclassiﬁed ABC protein (38). A single NEO-
containing cassette deleting LinJ32_V3.2190 (Figure 9A)
was electroporated in wild-type cells (Figure 9, lane 2), in
the Sb2000.1 mutant (Figure 9, lane 4) and in its revertant
(Figure 9, lane 6). PCR analysis of the integration con-
ﬁrmed that the cassette has integrated at the right locus
(Figure 9B). Southern blot analysis indicated that the inte-
gration of the NEO cassette in the WT strain led to
Figure 5. Extrachromosomal circular ampliﬁcation of a genomic region
encoding the MRPA gene on chromosome 23 of Leishmania.( A)
Genomic organization of the MRPA locus in L. infantum with the
Sb2000.1/WT microarrays expression ratios indicated underneath.
Direct repeats of 1.4kb are indicated by small boxes and the approx-
imate position of PCR primers 1a and 1b is indicated. (B) Model for
the formation of the extrachromosomal circular DNA generated
through homologous recombination between the direct repeats. (C)
Isolation of a circular DNA amplicon by standard alkaline lysis pre-
paration. The arrow head indicates the presence of the extrachromoso-
mal circular DNA. (D) PCR ampliﬁcation of a 1.8kb DNA fragment
with primers 1a and 1b to support the model shown in Figure 5B.
For (C) and (D), L. infantum wild type (lane 1); L. infantum
Sb2000.1 (lane 2).
Nucleic Acids Research,2009, Vol.37, No. 5 1393Figure 6. Chromosome aneuploidy in L. infantum Sb2000.1 and Sb4000.4 antimony-resistant mutants. Log2-transformed Sb2000.1/WT expression
ratios of the upregulated chromosome 1 (A), chromosome 11 (B) and chromosome 25 (C) and of the downregulated chromosome 9 (D), chromosome
12 (E) and chromosome 32 (F) plotted as a function of the location of microarray probes on each chromosomes. For each plot, the log2-transformed
gene expression ratios of chromosome 30, which was equally expressed in both samples, are shown as a control (grey line). Quantitative Southern
blot hybridizations of digested genomic DNA extracted from L. infantum WT (lane 1), Sb2000.1 (lane 2) and Sb4000.4 (lane 3) were performed to
correlate gene expression modulation of entire chromosomes with the chromosome DNA copy number. The hybridization signal of LinJ30_V3.2990
was used for normalization. The hybridization signals were quantiﬁed using ImageQuant 5.2 (Molecular Dynamics) and the fold diﬀerences in DNA
copy number of Sb2000.1 compared to WT are found below each blot.
1394 Nucleic Acids Research, 2009, Vol. 37,No. 5haploid parasites with one intact allele remaining for
the ABC protein gene (note the decrease in intensity of
50% between lane 1 and lane 2 in Figure 9C). However,
the ABC protein gene was deleted after a single round of
inactivation with the NEO cassette in the Sb2000.1 mutant
and its revertant (Figure 9C, lanes 4 and 6), a situation
usually not observed as Leishmania is a diploid organism.
These LinJ32_V3.2190 null mutant parasites grew as their
control parent cells and their susceptibility to antimonials
was unchanged (data not shown).
DISCUSSION
Microarrays monitoring gene expression are now being
used for the study of various aspects of Leishmania.
The initial studies have dealt with a limited number of
genes but genome-wide surveys are now being reported
(39,40,52–54). Gene expression studies using whole-
genome 70-mer oligonucleotide microarrays revealed the
complexity of the genotype associated with antimony
resistance in the L. infantum Sb2000.1 mutant. Indeed,
several genes showed a signiﬁcant diﬀerence in expression
compared to the parental sensitive WT strain, some of
which were part of an extrachromosomal amplicon while
others were located on aneuploid chromosomes. The set
of diﬀerentially regulated genes between L. infantum WT
and Sb2000.1 included two ABC protein-coding genes,
LinJ11_V3.0040/ABCH1 and LinJ23_V3.0290/MRPA.
The genome-wide survey reported here revealed that the
overexpression of ABCH1 is due to an increase in the
Figure 7. Comparison of relative hybridization data between RNA expression proﬁling and CGH. RNA- or genomic DNA-derived probes were
prepared from L. infantum Sb2000.1 and its sensitive parent strain and hybridized to DNA microarrays. A subset of whole chromosome comparisons
showing the correlation between RNA and DNA hybridization data is shown. Examples shown are: chromosomes 1 and 11 showing increased RNA
and DNA levels, chromosome 32 showing decreased RNA and DNA levels between the two strains and chromosome 30 where either RNA or DNA
remained unchanged. The expression ratio of each gene is indicated as orange to red features for overexpressed genes, pale to bright green features
for downregulated genes and yellow features for non-modulated genes.
Figure 8. Stability of the extrachromosomal circular amplicon and of chromosome aneuploidy in the revertant strain L infantum Sb2000.1rev.
(A) Extrachromosomal circular amplicon isolated by alkaline lysis. The arrow head indicates the presence of the extrachromosomal circular
DNA. (B) Quantitative Southern blot hybridizations of digested genomic DNA hybridized with probes speciﬁc to chromosomes 1, 11, 25 and 30
(as a control). (C) Quantitative Southern blot hybridizations of digested genomic DNA hybridized with probes speciﬁc to chromosomes 12, 32 and 30
(as a control). For (B) and (C), L. infantum WT (lane 1), L. infantum Sb2000.1 (lane 2), L. infantum Sb2000.1 grown for 5 (lane 3), 10 (lane 4), 20
(lane 5) and 30 (lane 6) passages in the absence of SbIII. The hybridization signals of LinJ30_V3.2990 located on a chromosome equally expressed
between L. infantum WT and Sb2000.1 were used for normalization of Southern blot hybridization signals. Fold diﬀerences in hybridization
intensities between L. infantum Sb2000.1 and WT are indicated below the Southern blots.
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microarrays were useful to map precisely the ampliﬁed
region encoding MRPA and three other genes on chromo-
some 23. Homologous recombination events that occured
between direct repeats that bordered this ampliﬁed locus
were responsible for the generation of the circular ampli-
con isolated from Sb2000.1. Gene ampliﬁcation through
homologous recombination between repeated sequences is
a common mechanism of drug resistance in Leishmania
(24,25,49,50,55,56) and is probably a consequence of the
lack of transcriptional control in trypanosomatid parasites
(57). Indeed, gene-speciﬁc expression modulation hap-
pened only for a limited number of genes and genes with
a substantial variation in RNA levels were part of an
amplicon generated by DNA recombination events.
Accordingly, repeated sequences may ﬂank key drug resis-
tance genes to allow their ampliﬁcation under conditions
where an increase of a speciﬁc protein is required.
Consistent with this proposal, the direct repeats ﬂanking
the MRPA locus on chromosome 23 are conserved in
L. infantum, L. major and L. braziliensis, despite 15 million
years of divergence (58).
It is plausible that Leishmania could resort to aneu-
ploidy to modulate the expression of relevant genes in
the absence of direct or inverted repeats in the vicinity
of a resistance gene or if more than one gene on a partic-
ular chromosome is required to confer resistance. Indeed,
analysis of our microarrays data showed that gene expres-
sion modulation of entire chromosomes (e.g chromosomes
1, 11, 12, 25 and 32) was associated with a concomitant
change in ploidy in the Sb2000.1 antimony-resistant strain
(Figures 6 and 7). The only exception was the minor
decrease in gene expression of chromosome 9 that
was not correlated to a change in copy number. This phe-
nomenon was previously observed in a L. major metho-
trexate-resistant strain (40) and may involve some
epigenetic mechanisms that remain to be elucidated.
Supernumerary chromosomes have already been described
when attempting to inactivate essential genes in
Leishmania (59,60) and drug-resistant parasites could
also increase the copy number of chromosomes carrying
genes relevant to resistance as recently demonstrated in
methotrexate-resistant Leishmania (40). In support for
this hypothesis, whole-chromosome aneuploidy and spe-
ciﬁc segmental aneuploidy have already been observed for
chromosomes encoding drug resistance genes in azole-
resistant strains of Candida albicans (51,61) and in drug-
resistant carcinomatous lung cancer cells (62). The
decreased expression of genes present on chromosomes
12 and 32 resulted from the loss of one copy of their chro-
mosome and led to a partial haploid mutant.
While segmental haploidy could be induced by telomere-
mediated chromosome fragmentation (63), this is the ﬁrst
example of drug-induced haploidy in Leishmania. The
antimony-related metalloid arsenite is known to induce
several mitotic abnormalities such as derangement of the
spindle apparatus and alteration of chromosome segrega-
tion (64) and it is possible that haploidy, coming from
the loss of speciﬁc chromosomes, could be associated
with antimony resistance in Leishmania, as previously
described for ovarian carcinoma cell lines selected for
resistance to microtubules stabilizing agents (65). The
mutant strain Sb2000.1 which is haploid for two chromo-
somes had no growth defect as promastigotes and also
infected macrophages similarly to wild-type parasites (37).
A role for aneuploidy in Leishmania drug resistance is
supported by the presence of similar changes in ploidy for
two chromosomes in the independently selected Sb2000.1
and Sb4000.4 antimony-resistant strains (Figure 6) and by
the correlation observed between SbIII resistance levels
and the copy number of aneuploid chromosomes in
Sb2000.1 (Figures 1 and 8). Accordingly, given that super-
numerary chromosomes have also been observed in a
L. major strain selected for methotrexate resistance (40),
it is possible that alterations in the number of copies of
speciﬁc chromosomes could be associated with gene
expression changes implicated in drug resistance in
Leishmania. Obviously, further work will be required to
identify which genes, if any, could be associated with anti-
mony resistance in Sb2000.1. One potential candidate
could be LinJ11_V3.0710, a gene located on chromosome
11 that is supernumerary in the two tested SbIII-resistant
Figure 9. Monosomy of chromosome 32 in L. infantum Sb2000.1 and L. infantum Sb2000.1rev. (A) Genomic organization of the LinJ32_V3.2190
region. The LinJ32_V3.2190 upstream and downstream fragments that were used to carry out gene disruption are shown. The primers 1 and 2 used
to conﬁrm the integration of the inactivation cassette at the LinJ32_V3.2190 locus are shown. ‘H’ represents HindIII restriction sites. (B) PCR
ampliﬁcation to conﬁrm the integration of the inactivation cassette. (C) Southern blot of L. infantum genomic DNA digested with HindIII and
hybridized to a LinJ32_V3.2190 probe (top) or a LinJ30_V3.2990 probe as a control (bottom). For (B) and (C), L. infantum WT (lane 1), L. infantum
WT with one LinJ32_V3.2190 allele disrupted (lane 2), L. infantum Sb2000.1 (lane 3), L. infantum Sb2000.1 with one LinJ32_V3.2190 allele disrupted
(lane 4), L. infantum Sb2000.1rev P30 (lane 5), L. infantum Sb2000.1rev P30 with one LinJ32_V3.2190 allele disrupted (lane 6).
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ATPase homologous to the bacterial ArsA protein.
Although ArsA homologs were not thought to be involved
in metal resistance in eukaryotes, it has recently been
reported that downregulation of the ArsA homolog in
Caenorhabditis elegans (asna-1) resulted in sensitization
of the worm to antimony and to the related metalloid
arsenite (66). However, transfection of this gene did not
reveal a role in SbIII resistance in Leishmania (our unpub-
lished data), and thus other candidates must be studied.
Finally, the LinJ05_V3.0830 gene encoding a methy-
lthioadenosine phosphorylase (MTAP) was downregu-
lated several folds in many independent L. infantum
SbIII-resistant mutants (Figure 3). A direct link with anti-
mony resistance is still missing but the downregulation
of this gene might be a good biomarker candidate for
predicting SbIII resistance, at least in L. infantum para-
sites. The genes ﬂanking LinJ05_V3.0830 were not diﬀer-
entially expressed between L. infantum WT and Sb2000.1
(data not shown) and this suggests that its speciﬁc down-
regulation could be mediated by changes in mRNA sta-
bility (67,68). MTAP is part of the methionine recycling
pathway and downregulation of its homologue in yeast
(meu1) is associated with an increase in ornithine decar-
boxylase (ODC) activity (69). ODC is frequently overex-
pressed (19,33) along with GSH1 (16,33) in metal-resistant
Leishmania mutants in order to increase the synthesis of
TSH, a key player of antimony resistance in trypanoso-
matid parasites. Interestingly, ODC (LinJ12_V3.0100)i s
located on chromosome 12 which has lost a copy in
Sb2000.1 and Sb4000.4. Accordingly, downregulation of
LinJ05_V3.0830 may be linked to the decreased polyamine
pool generated by the haploidy of chromosome 12.
Further experimental work will be required to test this
hypothesis but it is interesting to note that a correlation
between expression of speciﬁc genes and aneuploidy has
already been described in Saccharomyces cerevisiae (70).
Overall, the whole-genome expression proﬁling exp-
eriments enabled the identiﬁcation of several genotypic
changes associated with antimony resistance in
Leishmania. Although few genes identiﬁed in this study
displayed a dramatic modulation in expression, the anti-
mony-resistant phenotype may occur from the synergistic
interactions of several genes. With the exception of
MRPA, the expression of several genes known to be
involved in antimonials resistance (see ‘Introduction’ sec-
tion) was not modulated in the Sb2000.1 mutant, which
suggests that several mechanisms can lead to resistance.
The arrays also allowed the identiﬁcation of two novel
phenomenons, including partial haploidy and supernu-
merary chromosomes. Further work is required to isolate
the putative resistance genes located on aneuploid chro-
mosomes and should also reveal how widespread these
changes in chromosome copy number in Leishmania
isolates are.
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